Recent advances in the treatment of opioid use disorders–focus on long-acting buprenorphine formulations

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 9

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Psychiatry

ISSN

2220-3206

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Psychiatr. Sep 19, 2021; 11(9): 543-552
Published online Sep 19, 2021. doi: 10.5498/wjp.v11.i9.543

Table 2 Pharmacological options in the treatment of opioid use disorders

Citation: Soyka M, Franke AG. Recent advances in the treatment of opioid use disorders–focus on long-acting buprenorphine formulations. World J Psychiatr 2021; 11(9): 543-552
URL: https://www.wjgnet.com/2220-3206/full/v11/i9/543.htm
DOI: https://dx.doi.org/10.5498/wjp.v11.i9.543

Soyka M, Franke AG. Recent advances in the treatment of opioid use disorders–focus on long-acting buprenorphine formulations. World J Psychiatr 2021; 11(9): 543-552 [PMID: 34631459 DOI: 10.5498/wjp.v11.i9.543]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.